Andreas has during the last 7 years worked with pharmaceutical development in smaller companies. Since joining Stayble as the CEO in 2014 Andreas has developed the company from selection of the candidate drug through preclinical development and successful clinical trials. Andreas has an engineering background and a master’s in economics and Venture Creation from Chalmers University of Technology.
andreas.gerward@stayble.se+46 (0)730 808 397
Financial Calendar
Interim report Q1 2021
17May2021
Interim report Q2 2021
16August2021
Interim report Q3 2021
18November2021
IR Contact
M. Sc, CEO.Andreas Gerward
Andreas has during the last 7 years worked with pharmaceutical development in smaller companies. Since joining Stayble as the CEO in 2014 Andreas has developed the company from selection of the candidate drug through preclinical development and successful clinical trials. Andreas has an engineering background and a master’s in economics and Venture Creation from Chalmers University of Technology.
andreas.gerward@stayble.se+46 (0)730 808 397
We use cookies to improve the user experience on Stayble Therapeutics. Read more about Cookies